INTRODUCTION

Diabetic kidney disease (DKD) is one of the most common complications of diabetes. The prevalence of DKD in China is about 20% to 40%, and it has become the second cause of endstage renal disease in China, which seriously affects the quality of life in patients with diabetes [1]. At the same time, the treatment of DKD brings a heavy economic burden to patients, their families and the whole society [2]. Clinically, the early diagnosis of DKD is usually based on the level of microalbuminuria. However, once the diagnosis of DKD is made, the kidney has been irreversibly damaged. About one-third of the patients’ condition will progress and deteriorate even if active intervention is carried out [3]. If preventive intervention was carried out for all diabetes patients, it would consume huge human resource and medical expenses. Considering that the risk of DKD in some diabetes patients is not high, to save medical expenses, it is very important to screen out the diabetes patients with high risk of DKD for future preventive intervention, therefore, a smart screen tool is needed.

Scholars used statistical methods such as meta-analysis and regressions to construct risk predictive models of DKDs [4,5]. However, the scoring systems of these models were roughly developed by researchers, and furthermore, they predict the risk of DKD based on the baseline data, without considering the variability through years, resulting in lower accuracy. We used data from Taiwan externally validated a predictive formula published on diabetes care [4], and found that it’s accuracy, precision, and recall were all low (60.9%, 43.2%%, and 53.0%, respectively) [6], indicating that the performance of the formula was not ideal.

Conventional machine learning methods, such as random forest, decision tree, and support vector machine (SVM), were used to develop DKD predictive models for type 2 diabetes mellitus (T2DM) patients, found that the performance of the models based on machine learning technology is obviously superior to the statistical regression based formulas [7,8]. However, these shallow artificial neural networks have limited speed and room for data training. It has to manually select and adjust the features, and are prone to over-fitting phenomenon [9], which show a high level of accuracy/precision in the process of model training, but the accuracy/precision is much lower during the testing process.

In recent years, the development of deep learning technology brings new ideas for accurate prediction of DKD. It can explore the deeper features of data, which has attracted the interest of scholars in research and clinical fields [10]. In the medical field, deep learning techniques can be used to predict the risk of disease, including breast cancer risk prediction [11-13], cardiovascular disease risk [14-16], and risk of acute respiratory disease events and death in smoking patients [17]. In imaging diagnosis, it has been used in the diagnosis and grading of diabetes retinopathy [18-21] and the diagnosis of pulmonary nodules [22]. A large number of studies have confirmed that the prediction and diagnosis tools based on deep learning technology has high accuracy, fast speed, and greatly saves labor cost, showing a strong application prospect [23]. As a type of deep learning technique, long short term memory (LSTM) networks with memory and timing, has unique advantages in fully considering the impact of previous data on subsequent outcomes [24-26].

At present, there is only one study from Japan that uses deep learning technology to build a DKD predictive model for T2DM. They extracted raw features from the previous 6 months as the reference period and selected 24 factors to find time series patterns relating to 6-month DKD aggravation, with predictive accuracy of 71% [27]. A 6-month was rather too short, and to improve the performance of predictive model, data with longer duration of follow-up is needed.

Previous studies have confirmed that the variability of glycosylated hemoglobin (HbA1c), systolic blood pressure (SBP) and pulse pressure (PP) is the key influencing factor of the development and development of DKD [28-30]. However, most current studies did not consider the influence of variability parameters on the outcome when predicting the risk of DKD.

This study intends to develop a deep learning based model to predict risks of DKD in patients with diabetes, and evaluate it’s accuracy, precision and area under the curve (AUC) in predicting the DKD risk. We would also analyze the impact of the variability of HbA1c, SBP and PP on the overall performance of the model.

METHODS

Screening of predictive risk factors

Literature review

A literature review group was formed to identify the risk factors for DKD. We searched the databases of PubMed, EBSCO, Web of Science, and Chinese database (CNKI, VIP, and Wanfang), using key words “diabetic kidney disease”/“diabetic nephropathy” and “risk factor”/“predictive factor”/“associated factors”/ “predictor/”. Then a systematical review were produced.

Focus group of physicians

The risk factors identified from the literature were reviewed by a focus group of five endocrinologists and four nephrologists. The session lasted 95 minutes. The PI facilitated the session using a semi-structured discussion guide. A research assistant took notes and record responses. The physicians were presented with a handout containing the risk factors and asked to (1) rate the importance of each risk factor on a five-point scale, from 1 (very unimportant) to 5 (very important); (2) suggest additional risk factors considered important for DKD. We then develop a list of risk factors for DKD, which was reviewed by a senior endocrinologist and a senior nephrologist.

Data source for developing the DKD risk model

The data were from Lee’s United Clinic Taiwan. Lee’s United Clinic comprised of six clinics providing multidisciplinary care for patients with diabetes. Taiwan Health Insurance Plan supports four annual follow-up visits along with access to medications, diabetes supplies, diabetes self-management education clinician visitation and primary/secondary prevention screening to patients living with diabetes.

The T2DM patients, aged ≥18 years, with urinary albumin creatinine ratio (UACR) <30 mg/g and estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m², and who regularly followed up at clinics at least for 7 years were eligible for inclusion. The patients who were diagnosed with DKD at baseline and during the initial 2-year follow-up, with important data missed, with unclear pre-post relationship between nephropathy and diabetes, and fewer than two visits per year were excluded.

The Diagnostic criteria for DKD, following Chinese Clinical Guideline for Prevention and Treatment of Diabetes Nephropathy with eGFR <60 mL/min/1.73 m² and/or UACR ≥30 mg/g (for more than 3 months or longer) [31].

Data collection

Ideally, data should include the risk factors identified from literature review and focus group, but cystatin C were not checked during the follow-up, so it was not included.

Demographic data: Age, gender, height, weight, smoking, alcohol consumption, marital status, diabetes duration, family history, education level, yearly income, medication history, and comorbidities (coronary heart disease, stroke, diabetes retinopathy, diabetes foot, and non-alcoholic fatty liver disease, etc.).

Clinical data: Following data were collected at least twice a year: body mass index (BMI), waist-hip-ratio, SBP, diastolic blood pressure, eGFR, UACR, urine protein, serum creatinine (Scr), fasting plasma glucose, fasting insulin, HbA1c, 2-hour postprandial glucose after meals, homeostasis model assessment of β-cell function, homeostasis model assessment of insulin resistance, triglyceride, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (HDLC), and variability of HbA1c, SBP, and PP during follow-up. Variability of HbA1c, SBP, and PP was defined as standard deviation (SD) from the average levels of HbA1c, SBP, and PP by calculating average values of HbA1c, SBP, and PP measurements and their SDs for each patient during the entire study period [32].

Data processing and dividing

We design the LSTM neural networks using 2 years data to predict the risk in the next 5 years, so we used 7 consecutive years data to develop the model. We process the data as following steps: (1) screen out the patients who did not develop DKD in 7 years follow-up, and marked as 0; (2) screen out the patients without DKD in the first 2 years, but developed DKD in the next 5 years, and marked as 1. Then the data were divided into two sets: 70% in the training set, and 30% in the testing set.

LSTM neural networks building

Pytorch language was used to build the networks. After the LSTM neural networks was set, the data of training set was inputted to the networks, training the LSTM networks, enabling the networks learning the features of the data, and comparing the output results with marked result, as previously described (0 represents did not developed DKD and 1 represents developed DKD). The difference values were propagated back to achieve continuous corrections and adjustments of the neural network parameters, and finally the network model achieves the optimum status. After the model is trained to the optimal state by using the training set data, the data in testing set were used to test the model’s performance.

Dropout was used to prevent the over-fitting phenomenon (the model appears to have a high accuracy in the training process, but have a much lower predictive accuracy in the test process when use the testing data set). We used dropout to solve the problem, and 20% of the neural nerves were randomly removed. The construction process of the structural design of the LSTM neural network prediction model constructed in this study is illustrated in Table 1.

For disease risk prediction models, the smaller the difference between the predicted risk value and the actual disease risk, the more the more prediction accuracy. The loss function is used to measure the gap between the predicted value and the actual value. The most commonly used loss function, mean squared error (MSE), was in this study to calculate the absolute error between the real value and the estimated value. The smaller the value of MSE, the better the prediction value of the model. The functional expression is as follows (1):

(1)

MSE=1n∑i=1nwiyi-y^i2

Network training and output results

In this study, the network was trained with a learning rate of 10^-3 epoch, 5,000; loss function, MSE; mini-batch size, 50; optimizer, adam optimization algorithm. Given that this model is used to predict the future risk of DKD in T2DM patients, its prediction result should be the probability value distributed in the (0–1) interval. We then designed the output of the neural network, which needs to be constrained. In this study, a sigmoid function is employed, which is expressed as follows (2):

(2)

St=11+e-t

Through this function, any real number of the output of the network in this study would be mapped to the interval of 0–1, that is, the output result can express the probability value of the network for a certain classification.

Evaluation of the model performance

The predictive accuracy, precision, recall and the AUC of the receiver operating characteristic (ROC) curve were used to evaluate the performance of the model. AUC ≤0.5 means the model does not have the predictive value; AUC ≤0.7, AUC >0.8, AUC >0.9; represent the performance of the model is low, good, and great, respectively. The overall performance of the pre-trained models is evaluated using four criteria (TP, true positive; TN, true negative; FP, false positive; and FN, false negative). The system’s performance is assessed by using the Equations 3 to 5:

(3)

Accuracy=TP+TNTP+TN+FP+FN

(4)

Precision=TPTP+FP

(5)

Recall=TPTP+FN

Statistical analysis

After all data were collected and processed, the data were finally entered into Excel 2016 software by double check and the related database was established. Using SPSS version 22.0 software (IBM Co., Armonk, NY, USA) to determine the correlation coefficient of each parameter, MATLAB simulation software and pytorch language were used for data extraction, data set processing, LSTM neural network design, network training and result output. ROC curve was used to calculate the AUC, indicating the discrimination of the model. The chi-squared test was used for inter-group comparisons of accuracy, precision, and recall; and the z-test was used for AUC comparisons. There is a statistical difference when the P value is less than 0.05.

Institutional Review Board statement

This study involves human participants and was approved by Human Trial Review Committee of Taiwan Lee’s United Clinic (No.14-055-B2). Participants gave informed consent to participate in the study before taking part.

RESULTS

DKD risk predictors

This study analyzed and summarized the risk factors of DKD based on literature review and physician focus group. After the focus group interviews, we removed some attributes such as “tea drinking,” “high fat diet,” “sweet food” reported from single Chinese paper, and “genes.” Of course, genetic factors are very important for DKD development, but it is expensive and not commonly checked. The attributes must included, but not limited in data collection were as follows: older age, longer duration of diabetes, family history of DKD, smoking, diabetes retinopathy, mean HbA1c, hypertension, without regular exercise, high blood uric acid, insulin resistance, high BMI, SBP, HDL-C, triacylglycerol (TG), UACR, and cystatin C, meat intake, number of oral hypoglycemic drugs. The variability of HbA1c, SBP, and PP were also the predictors of DKD (Table 2). The important predictors the machine selected were (from higher weight size to lower weight size): Scr, age, HDL-C, HbA1c, PP, SBP, TG, variabilities of HbA1c, SBP, and PP.

Performance comparison between LSTM and SVM models

Based on the 7-year consecutive data of Lee’s United Clinic in Taiwan, the model was trained to use the first 2 years data to predict the DKD risk in next 5 years. According to the inclusion and exclusion criteria, a total of 6,040 T2DM patients were included in the study, and 30% (1,812 cases) of which were divided into the test set. Diabetes patients (n=1,268) did not develop DKD and 544 patients developed DKD.

The prediction performance of LSTM model were: 411 TP, 120 FP, 133 FN, and 1,148 TN, while for the SVM model, 283 TP, 163 FP, 261 FN, and 1,105 TN. Therefore, in this study, the precision of the LSTM model was 411/(411+120)×100%=77%, while the precision of the prediction model constructed based on SVM algorithm was 283/(283+163)×100%=63%, and the precision of the LSTM model was higher (F=128.521, P<0.001). The accuracy of LSTM model was (411+1,148)/(411+1,148+120+133)×100%=86%, much higher than that of SVM model: (283+1,105)/(283+1,105+163+261)×100%=76% (F=71.785, P<0.001). The recall for LSTM model was 411/(411+133)×100%=76%, much better than that of SVM model: 283/(283+261)×100%=52% (F=226.598, P<0.001). Thus, the overall performance of LSTM model superior to that of SVM model (Fig. 1).

In this study, the optimal cutoff point and AUC for LSTM model were 0.55 and 0.83 and which of the SVM model were 0.75 and 0.73 indicating that the performance of the LSTM model was superior to that of SVM algorithm. The ROC curves of the two are shown in Fig. 2.

Impact of variability parameters on the DKD prediction

To verify the effects of the variability of HbA1c, SBP, and PP on the performance of the model, three neural network models were constructed, with each model excluded HbA1c variability, SBP variability, or PP variability, were compared with the optimal prediction model which include all the variability parameters (Table 3).

Comparison of accuracy and AUC area of DKD models

The results show that the best cutoff point of the optimal LSTM prediction model with all variability parameters is 0.55, and the AUC value is 0.83. When we remove the risk factor of HbA1c, SBP, or PP variability one by one, the accuracy of each model were 78% (P<0.001), 79% (P<0.001) and 81% (P<0.001), and the best cutoff point for the DKD risk predictive models were 0.60, 0.55, and 0.60, respectively, with AUC values of 0.72, 0.75, and 0.77, respectively (Fig. 3). The comparison between the model included all HbA1c, SBP, or PP variabilities with other models, which missed one of three variabilities, that the AUC of LSTM model with all variability parameters was significantly better than that of the other three prediction models, all P< 0.05, indicating that the inclusion of variability parameters such as HbA1c, SBP, and PP can significantly increase the overall performance of the model.

DISCUSSION

In this study, we used LSTM neural network developed DKD risk prediction model for diabetes patients, with high accuracy and AUC. At the same time, HbA1c variability, SBP variability and PP variability were added as new risk factors of DKD to develop the DKD risk prediction model and improved the model’s performance.

At present, only one study from Japan successfully constructed the DKD risk prediction model using deep learning technology, with the accuracy of 71% and AUC of 0.743 [27]. The accuracy and AUC value of our study were higher. The following reasons may explain the difference. First, the different deep learning technology made the difference. The Japanese study used convolutional neural network while our study used LSTM neural network, and the latter has unique advantages over convolutional neural network in DKD risk model building, because LSTM has memory and timing concept, fully considering the impact of previous metabolic control on the occurrence of DKD subsequent years [33]. Second, before developing the model, we not only identified the risk factors through systematical reviews physician specialists focus group, but also included HbA1c, SBP, and PP variability as important characteristic parameters in the model for training. Compared with our study, the factors included in this Japanese study were only routine indexes of serum and urine tests of patients in the previous 6 months, such as blood glucose, HbA1c, and blood lipid, and did not fully consider the important influence of fluctuation of HbA1c and blood pressure on the development of DKD. Therefore, the feature parameters included in our study are more comprehensive and have more prediction value, which can improve the overall performance of the prediction model to a certain extent. Finally, our study used 7 years consecutive data while the Japanese study use 6 months data. Since the process of developing DKD is relatively long, involving years, so 6-month of data is not long enough to let DKD happen.

It was also demonstrated that in our study, when HbA1c, SBP, and PP variability were added as risk factors to the characteristic parameters to develop the model, the overall performance was significantly improved. Some studied demonstrated that HbA1c, SBP, and PP variabilities impacted the development of DKD in patients with T2DM [34], but the mechanism is still unclear, which may closely related to oxidative stress, endothelial dysfunction and increased inflammatory factors caused by the fluctuation of HbA1c, SBP, and PP. Oxidative stress, endothelial dysfunction, and increased inflammatory factors are key pathogenic factors leading to kidney tissue damage and impaired renal function leading to the development of DKD [35-39]. Further prospective studies are needed to elucidate the mechanism on the fluctuation of HbA1c, SBP, and PP impacting the development of DKD.

This study also has several limitations. First, the study subjects in this study were from Taiwan, and the factors impact DKD development may be partially influenced by the fact that there is a degree of variation in different regions. Second, the data used to train the model and test the performance of the model were from the same source. They were all from Taiwan Lee’s United Clinic, and this may affect the generalization of the model. So in the future, external validation is needed. Third, the overall performance of the model still has room for improvement; therefore, continues adjustment is warranted.

In conclusion, our study used LSTM neural networks to develop the DKD prediction model with higher performance, as indicated by precision, accuracy, recall, and AUC value. When variability of HbA1c, SBP, and PP was added to the model as featured characteristics, the performance of the model was greatly improved, which suggests that minimizing the variability of HbA1c, SBP, and PP would help to prevent DKD in patients with diabetes. The LSTM based DKD prediction model brings a new idea to screen diabetes patients with high risk of DKD, enabling precise early preventative interventions, so as to prevent DKD economically. The results not only urge patients and health care professionals to consider the important impact of variability of metabolic parameters on DKD development, but also provide new ideas and methods for developing predicting models for other chronic diseases such as diabetic retinopathy.

NOTES

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

AUTHOR CONTRIBUTIONS

Conception or design: Q.L.

Acquisition, analysis, or interpretation of data: C.Y., F.T., Z.G., W.W., F.B., H.L., Y.L., Q.L.

Drafting the work or revising: C.Y., F.T., J.D.M., Q.L.

Final approval of the manuscript: all authors.

FUNDING

This study was supported by National Key R&D program of China (2021YFE0204800) and Key R&D Program of Hainan Province (ZDYF2021SHFZ236).

Acknowledgements

The authors sincerely thank all participants for their time and effort in this study.

Fig. 1.

Comparison of precision, accuracy and recall of models constructed by long short term memory (LSTM) and support vector machine (SVM).

Fig. 2.

Comparison of receiver operating characteristic curves for the long short term memory (LSTM) and support vector machine (SVM) models. AUC, area under the curve.

Fig. 3.

Comparison of area under the curve areas among four diabetic kidney disease prediction models based on long short term memory (LSTM) neural network. PP, pulse pressure; SBP, systolic blood pressure; HbA1c, glycosylated hemoglobin.

REFERENCES

• 1. Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis 2018;25:121-32.ArticlePubMedPMC
• 2. Sever MS, Jager KJ, Vanholder R, Stengel B, Harambat J, Finne P, et al. A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community. Clin Kidney J 2020;14:23-35.ArticlePubMedPMCPDF
• 3. Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Nephrol Dial Transplant 2004;19:2784-8.ArticlePubMed
• 4. Jiang W, Wang J, Shen X, Lu W, Wang Y, Li W, et al. Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts. Diabetes Care 2020;43:925-33.ArticlePubMedPDF
• 5. Li L, Yang Y, Zhu X, Xiong X, Zeng L, Xiong S, et al. Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients. J Diabetes 2020;12:237-46.ArticlePubMedPDF
• 6. Sun Z, Wang K, Miller JD, Yuan X, Lee YJ, Lou Q. External validation of the risk prediction model for early diabetic kidney disease in Taiwan population: a retrospective cohort study. BMJ Open 2022;12:e059139.ArticlePubMedPMC
• 7. Xin L, Jin L, Lei L, Liang C, Huiling R. Risk prediction models of type 2 diabetic nephropathy. Chin J Med Libr Inf Sci 2019;28:41-5.
• 8. Gaoxing Q. To construct a predictive diagnostic model of diabetic nephropathy. Available from: https: https://kns.cnki.net/KCMS/detail/detail.aspx?dbname=CMFD201902&filename=1019115309.nh (cited 2023 Jul 14).
• 9. Mpanya D, Celik T, Klug E, Ntsinjana H. Machine learning and statistical methods for predicting mortality in heart failure. Heart Fail Rev 2021;26:545-52.ArticlePubMedPDF
• 10. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature 2015;521:436-44.ArticlePubMedPDF
• 11. Assegie TA. An optimized K-Nearest Neighbor based breast cancer detection. J Robot Control 2021;2:115-8.Article
• 12. Subramanian R, Rubi D, Lakshmi RG, Jain P, Kanneganti SR. Breast cancer lesion detection and classification in radiology images using deep learning. Eur J Mol Clin Med 2020;7:677-84.
• 13. Zhou LQ, Wu XL, Huang SY, Wu GG, Ye HR, Wei Q, et al. Lymph node metastasis prediction from primary breast cancer us images using deep learning. Radiology 2020;294:19-28.ArticlePubMed
• 14. Guo A, Beheshti R, Khan YM, Langabeer JR 2nd, Foraker RE. Predicting cardiovascular health trajectories in time-series electronic health records with LSTM models. BMC Med Inform Decis Mak 2021;21:5.ArticlePubMedPMCPDF
• 15. Lewis M, Elad G, Beladev M, Maor G, Radinsky K, Hermann D, et al. Comparison of deep learning with traditional models to predict preventable acute care use and spending among heart failure patients. Sci Rep 2021;11:1164.ArticlePubMedPMCPDF
• 16. Zeleznik R, Foldyna B, Eslami P, Weiss J, Alexander I, Taron J, et al. Deep convolutional neural networks to predict cardiovascular risk from computed tomography. Nat Commun 2021;12:715.ArticlePubMedPMCPDF
• 17. Gonzalez G, Ash SY, Vegas-Sanchez-Ferrero G, Onieva Onieva J, Rahaghi FN, Ross JC, et al. Disease staging and prognosis in smokers using deep learning in chest computed tomography. Am J Respir Crit Care Med 2018;197:193-203.ArticlePubMedPMC
• 18. Bellemo V, Lim ZW, Lim G, Nguyen QD, Xie Y, Yip MYT, et al. Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study. Lancet Digit Health 2019;1:e35-44.ArticlePubMed
• 19. Nielsen KB, Lautrup ML, Andersen JKH, Savarimuthu TR, Grauslund J. Deep learning-based algorithms in screening of diabetic retinopathy: a systematic review of diagnostic performance. Ophthalmol Retina 2019;3:294-304.ArticlePubMed
• 20. Raman R, Srinivasan S, Virmani S, Sivaprasad S, Rao C, Rajalakshmi R. Fundus photograph-based deep learning algorithms in detecting diabetic retinopathy. Eye (Lond) 2019;33:97-109.ArticlePubMedPMCPDF
• 21. Sayres R, Taly A, Rahimy E, Blumer K, Coz D, Hammel N, et al. Using a deep learning algorithm and integrated gradients explanation to assist grading for diabetic retinopathy. Ophthalmology 2019;126:552-64.ArticlePubMed
• 22. Jiang H, Ma H, Qian W, Gao M, Li Y, Hongyang Jiang, et al. An automatic detection system of lung nodule based on multigroup patch-based deep learning network. IEEE J Biomed Health Inform 2018;22:1227-37.ArticlePubMed
• 23. Miotto R, Wang F, Wang S, Jiang X, Dudley JT. Deep learning for healthcare: review, opportunities and challenges. Brief Bioinform 2018;19:1236-46.ArticlePubMedPMC
• 24. Hochreiter S, Schmidhuber J. Long short-term memory. Neural Comput 1997;9:1735-80.ArticlePubMed
• 25. Hua Y, Zhao Z, Li R, Chen X, Liu Z, Zhang H. Deep learning with long short-term memory for time series prediction. IEEE Commun Mag 2019;57:114-9.Article
• 26. Sak H, Senior A, Beaufays F. Long short-term memory based recurrent neural network architectures for large vocabulary speech recognition. ArXiv 2014 Feb 5 [Preprint]. https://doi.org/10.48550/arXiv.1402.1128.Article
• 27. Makino M, Yoshimoto R, Ono M, Itoko T, Katsuki T, Koseki A, et al. Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning. Sci Rep 2019;9:11862.ArticlePubMedPMCPDF
• 28. Xue C, Qianqian Z, Huijun X, Xiaodan Y, Chao L, Taojun L, et al. Effect of glycated hemoglobin A1c variability on diabetic kidney disease in type 2 diabetes mellitus patients. Chin J Diabetes Mellit 2020;12:993-8.
• 29. Luk AO, Ma RC, Lau ES, Yang X, Lau WW, Yu LW, et al. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 2013;29:384-90.ArticlePubMed
• 30. Viazzi F, Bonino B, Mirijello A, Fioretto P, Giorda C, Ceriello A, et al. Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes. J Hypertens 2019;37:805-13.ArticlePubMed
• 31. Microvascular Complications Group of Chinese Diabetes Society. Clinical guideline for the prevention and treatment of diabetic kidney disease in China (2021 edition). Chin J Diabetes Mellit 2021;13:762-84.
• 32. Lou Q, Chen X, Wang K, Liu H, Zhang Z, Lee Y. The impact of systolic blood pressure, pulse pressure, and their variability on diabetes retinopathy among patients with type 2 diabetes. J Diabetes Res 2022;2022:7876786.ArticlePubMedPMCPDF
• 33. Karim F, Majumdar S, Darabi H, Chen S. LSTM fully convolutional networks for time series classification. IEEE Access 2018;6:1662-9.Article
• 34. Zhu W, Xu L, Chen X, Lee YJ, Zhang Z, Lou Q. Effects of different blood pressures and their long-term variability on the development of diabetic kidney disease in patients with type 2 diabetes mellitus. Clin Exp Hypertens 2022;44:464-9.ArticlePubMed
• 35. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20.ArticlePubMedPDF
• 36. Ceriello A, Kilpatrick ES. Glycemic variability: both sides of the story. Diabetes Care 2013;36(Suppl 2):S272-5.ArticlePubMedPMCPDF
• 37. Chang CM, Hsieh CJ, Huang JC, Huang IC. Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol 2012;49 Suppl 1:S171-7.ArticlePubMedPDF
• 38. Chiu WC, Lai YR, Cheng BC, Huang CC, Chen JF, Lu CH. HbA1C variability is strongly associated with development of macroalbuminuria in normal or microalbuminuria in patients with type 2 diabetes mellitus: a six-year follow-up study. Biomed Res Int 2020;2020:7462158.ArticlePubMedPMCPDF
• 39. Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, Maggio P, et al. Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care 2011;34:1605-9.ArticlePubMedPMCPDF

Figure & Data

References

Citations

Citations to this article as recorded by  

• Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population‐based study
  Yifei Wang, Ting Lin, Jiale Lu, Wenfang He, Hongbo Chen, Tiancai Wen, Juan Jin, Qiang He
  Diabetes, Obesity and Metabolism.2025; 27(4): 1902.     CrossRef

About this article

Yun C, Tang F, Gao Z, Wang W, Bai F, Miller JD, Liu H, Lee Y, Lou Q. Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning. Diabetes Metab J. 2024;48(4):771-779.

Received: Feb 03, 2023; Accepted: May 27, 2023

DOI: https://doi.org/10.4093/dmj.2023.0033.

Download citation ↓